Yonsei Med J.  2002 Dec;43(6):754-762. 10.3349/ymj.2002.43.6.754.

Surgical Management of Recurrent Cervical Cancer

Affiliations
  • 1Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Clinical Hospital, Universidad de Chile, Santiago, Chile.
  • 2Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Ohio State University, Columbus Ohio, USA. copeland.7@osu.edu

Abstract

The majority of patients with recurrent cervical cancer are incurable and treatment is based on the type of primary therapy delivered. Only a very small percentage of the patients with recurrent cervical cancer following primary radiotherapy will have central pelvic recurrences that are amenable to surgical resection and curable by pelvic exenteration. These procedures should be undertaken only after the completion of exhaustive attempts to exclude extrapelvic disease.

Keyword

Cervix neoplasms; pelvic exenteration; recurrent cervical cancer; treatment outcome; quality of life; prognosis; survival rate; urinary diversion; colonic diversion; vaginal reconstruction; preoperative care; postoperative complications

MeSH Terms

Cervix Neoplasms/drug therapy/mortality/*surgery
Female
Human
Neoplasm Recurrence, Local/drug therapy/mortality/*surgery
Pelvic Exenteration/adverse effects/methods
Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr